NCT00850070 - Sapropterin as a Treatment for Autistic Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

October 31, 2011

Conditions

Autistic Disorder

Interventions

DRUG

sapropterin

Patients will receive sapropterin 20 mg per kilogram per day for 16 weeks

DRUG

Placebo

Patients will receive a placebo identical in form and dosage to the active drug daily for 16 weeks.

Trial Locations (1)

The Children's Health Council, Palo Alto